Teq Pharmaceuticals Private Limited
About Teq Pharmaceuticals Private Limited
Data last updated:
Teq Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 15 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2014PTC256076. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramkinkar Ramdular Rai and Ajeet Kumar Rai.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Beverly Park, Thane, Maharashtra.
As per the financials filed for FY 2018, the company reported a revenue of ₹94.02 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.01 Lakh (net margin 4.3%) and EBITDA of ₹6.83 Lakh (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Teq Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 7 Ostwal Orchid Bldg. No. 45 Prathmesh(Heritage) Beverly Park Mira R, Oad (East), Thane, Maharashtra, India – 401107
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Teq Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Teq Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Teq Pharmaceuticals Private Limited, buy the company report.
Financials of Teq Pharmaceuticals Private Limited
FY 2018 filings availableTeq Pharmaceuticals Private Limited reported revenue of ₹94.02 Lakh (up 346% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 90% over three years, including 346% growth in the latest year. EBITDA rose 280% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹6.83 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹4.01 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.3% | |||
| Net Profit Margin | 4.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Teq Pharmaceuticals Private Limited, buy the company report.
Board of directors of Teq Pharmaceuticals Private Limited
Teq Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajeet Kumar Rai | Additional Director | 12 Mar 2020 | 6 Years 7 Months | Current |
| Ramkinkar Ramdular Rai | Director | 15 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Teq Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Twenty Twenty Eye Care Private Limited | ₹94.22 Lakh (FY 2025) | -1.0% | Haridwar, Uttarakhand, India | |||
| Teq Pharmaceuticals Private Limitedthis company | ₹94.02 Lakh (FY 2018) | ₹4.01 Lakh | 4.3% | 346.0% | Thane, Maharashtra, India | |
| Ximar Healthcare Private Limited | ₹93.84 Lakh (FY 2025) | 67.0% | Kolkata, West Bengal, India | |||
| Medcliff Pharmaceuticals Private Limited | ₹93.68 Lakh (FY 2025) | 2.0% | Panchkula, Haryana, India |
To see the full peer comparison of Teq Pharmaceuticals Private Limited, buy the company report.
Auditor
Teq Pharmaceuticals Private Limited is audited by SSRV & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SSRV & ASSOCIATES | FY 2017 | 135901W |
Shareholding
The shareholding of Teq Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Teq Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Teq Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Teq Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Teq Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Teq Pharmaceuticals Private Limited, buy the company report.
Recent activity
Teq Pharmaceuticals Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Ajeet Kumar Rai was appointed as Additional Director on 12 Mar 2020.
Frequently asked questions
Teq Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 15 July 2014 (12+ years old) and is registered under CIN U74999MH2014PTC256076.
Teq Pharmaceuticals has 2 current directors:
- Ajeet Kumar Rai - Additional Director
- Ramkinkar Ramdular Rai - Director
The latest financial statements of Teq Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
No. Teq Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Teq Pharmaceuticals is U74999MH2014PTC256076. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Teq Pharmaceuticals was incorporated on 15 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Teq Pharmaceuticals by revenue are Twenty Twenty Eye Care Private Limited, Ximar Healthcare Private Limited, Medcliff Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ajeet Kumar Rai was appointed as Additional Director on 12 Mar 2020. Arjun Dipnarayan Pandey ceased to be Director on 12 Mar 2020. Manoj Balbir Sodha ceased to be Director on 30 May 2016. Teq Pharmaceuticals has 4 board changes on record in total.
The registered office of Teq Pharmaceuticals is at Shop No. 7 Ostwal Orchid Bldg. No. 45 PrathmeshHeritage Beverly Park Mira R, Oad East, Thane, Maharashtra, India – 401107.
Teq Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Teq Pharmaceuticals is active non-compliant as of 14 September 2026. The company is actively filing with the Registrar of Companies.